Generic Name and Formulations:
Hydrocodone bitartrate 7.5mg, acetaminophen 325mg; per 15mL soln; contains alcohol (7%); tropical fruit punch flavor.
Pharmaceutical Associates, Inc.
Indications for HYCET:
Moderate to moderately severe pain.
Administer with calibrated measuring device. ≥14yrs (≥46kg): 15mL every 4–6 hours as needed; max 90mL/day.
<2yrs: not recommended. Administer with calibrated measuring device. Dosing should be based on weight (0.27mL/kg). 2–3yrs (12–15kg): 3.75mL. 4–6yrs (16–22kg): 5mL. 7–9yrs (23–31kg): 7.5mL. 10–13yrs (32–45kg): 10mL. All: give every 4–6 hours as needed; max: 6 doses/day.
Head injury. Increased intracranial pressure. Acute abdomen. Impaired renal, hepatic, thyroid, pulmonary, or adrenocortical function. Severe renal or hepatic disease: monitor liver and renal function tests periodically. GI or GU obstruction. Post-op use. Drug abusers. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C) (neonatal withdrawal syndrome). Nursing mothers: not recommended.
Opioid + analgesic.
Potentiation with alcohol, other CNS depressants (eg, antihistamines, antipsychotics, antianxiety drugs). May potentiate or be potentiated by MAOIs, tricyclic antidepressants.
CNS/respiratory/circulatory depression, hypotension, dizziness, GI upset, constipation, urinary retention, rash; hepatotoxicity (overdosage).
Soln—473mL (1 pint)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- FDA Approves New Treatment for Opioid Dependence
- Gestational Diabetes Associated With Increased Risk for Postpartum Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Smartphone-Based Psychoeducational Programs May Be Effective for Bipolar Disorder Management
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Risk Factors for Recurrent Suicide Attempts in Substance Use Disorder Outpatients